NovoCure Limited (NVCR) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against NovoCure LimitedBusiness Wire • 06/27/23
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)Business Wire • 06/27/23
NVCR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire • 06/26/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited (NVCR)Business Wire • 06/26/23
ROSEN, LEADING TRIAL ATTORNEYS, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - NVCRPRNewsWire • 06/24/23
NVCR INVESTOR DEADLINE: NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitPRNewsWire • 06/24/23
NOVOCURE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCRPRNewsWire • 06/24/23
Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC TodayBusiness Wire • 06/23/23
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) InvestorsBusiness Wire • 06/23/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) InvestorsBusiness Wire • 06/22/23
Calling All Investors in NovoCure Limited (NVCR): New Lawsuit Lead Plaintiff Deadline Is August 18, 2023 - Contact Bronstein, Gewirtz & Grossman, LLC TodayBusiness Wire • 06/22/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of NovoCure Limited (NVCR) InvestorsBusiness Wire • 06/21/23
EQUITY ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages NovoCure Limited Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NVCRBusiness Wire • 06/21/23
Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against NovoCure Limited (NASDAQ: NVCR); Lead Plaintiff Deadline is August 18, 2023Business Wire • 06/21/23
Calling all investors in NovoCure Limited (NVCR): New lawsuit lead plaintiff deadline is August 18, 2023 - contact Bronstein, Gewirtz & Grossman, LLC todayPRNewsWire • 06/21/23
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NovoCure Limited (NVCR)Business Wire • 06/20/23
NOVOCURE SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against NovoCure Limited - NVCRBusiness Wire • 06/20/23
NVCR NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of NovoCure LimitedPRNewsWire • 06/20/23
NVCR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that NovoCure Limited Investors with Substantial Losses Have Opportunity to Lead the NovoCure Class Action LawsuitBusiness Wire • 06/20/23
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $100,000 to Contact the FirmBusiness Wire • 06/20/23
INVESTOR LAWSUIT HAS BEEN FILED: The Schall Law Firm Encourages Investors in NovoCure Limited with Losses of $250,000 to Contact the FirmAccesswire • 06/20/23
NOVOCURE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against NovoCure Limited and Encourages Investors to Contact the FirmBusiness Wire • 06/20/23
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses to Contact the FirmAccesswire • 06/18/23
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NovoCure Limited and Encourages Investors with Losses In Excess of $250,000 to Contact the FirmAccesswire • 06/17/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of NovoCure Limited (NVCR) on Behalf of InvestorsBusiness Wire • 06/16/23
